Literature DB >> 10073799

Left ventricular versus biventricular dysfunction in idiopathic dilated cardiomyopathy.

L La Vecchia1, M Paccanaro, C Bonanno, L Varotto, R Ometto, M Vincenzi.   

Abstract

Eighty-five consecutive patients with idiopathic dilated cardiomyopathy were categorized according to the presence (biventricular dysfunction) or absence (left ventricular [LV] dysfunction) of reduced right ventricular ejection fraction (<35%) along with reduced LV ejection fraction (<50%). Compared with the 36 patients with LV dysfunction, the 49 patients with biventricular dysfunction had significantly worse New York Heart Association functional class (2.7+/-0.6 vs 1.9+/-0.5; p <0.001), LV ejection fraction (26+/-10% vs 34+/-8%; p <0.0001), and outcome (transplant-free survival, 55% vs 89%; p <0.001). Thus, dilated cardiomyopathy is frequently characterized by biventricular involvement, which identifies a more severe disease and a worse long-term prognosis.

Entities:  

Mesh:

Year:  1999        PMID: 10073799     DOI: 10.1016/s0002-9149(98)00795-4

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  10 in total

1.  Dose dependent but non-linear effects of alcohol on the left and right ventricle.

Authors:  O A Kajander; M Kupari; P Laippala; V Savolainen; J Pajarinen; A Penttilä; P J Karhunen
Journal:  Heart       Date:  2001-10       Impact factor: 5.994

Review 2.  Utility of echocardiography in the evaluation of individuals with cardiomyopathy.

Authors:  Malissa J Wood; Michael H Picard
Journal:  Heart       Date:  2004-06       Impact factor: 5.994

Review 3.  Do we have two hearts? New insights in right ventricular function supported by myocardial imaging echocardiography.

Authors:  Antonio Vitarelli; Claudio Terzano
Journal:  Heart Fail Rev       Date:  2010-01       Impact factor: 4.214

Review 4.  Echocardiographic evaluation of the right ventricle: a 2014 perspective.

Authors:  Shoshana Gal Portnoy; Lawrence G Rudski
Journal:  Curr Cardiol Rep       Date:  2015       Impact factor: 2.931

5.  Right ventricular ejection fraction <20% is an independent predictor of mortality but not of hospitalization in older systolic heart failure patients.

Authors:  Philippe Meyer; Ravi V Desai; Marjan Mujib; Margaret A Feller; Chris Adamopoulos; Maciej Banach; Mitja Lainscak; Inmaculada Aban; Michel White; Wilbert S Aronow; Prakash Deedwania; Ami E Iskandrian; Ali Ahmed
Journal:  Int J Cardiol       Date:  2011-06-12       Impact factor: 4.164

6.  Selection of patients for cardiac resynchronisation therapy (CRT) in an unselected heart failure population.

Authors:  C M H B Lucas; G V J Cleuren; C J H J Kirchhof
Journal:  Neth Heart J       Date:  2006-01       Impact factor: 2.380

7.  Can fractional excretion of sodium predict worsening of renal function, in-hospital mortality, and length of hospital stay in acute decompensated heart failure?

Authors:  Farzaneh Ahmadi; Ekhlas Torfi; Sayed Mohammadreza Afshani; Saadat Kazemi-Mansourabad; Fatemeh Hayati
Journal:  ARYA Atheroscler       Date:  2021-11

Review 8.  Devices in heart failure: potential methods for device-based monitoring of congestive heart failure.

Authors:  Shahzeb M Munir; Roberta C Bogaev; Ed Sobash; K J Shankar; Sreedevi Gondi; Igor V Stupin; Jillian Robertson; M Alan Brewer; S Ward Casscells; Reynolds M Delgado; Amany Ahmed
Journal:  Tex Heart Inst J       Date:  2008

9.  Effects of right ventricular ejection fraction on outcomes in chronic systolic heart failure.

Authors:  Philippe Meyer; Gerasimos S Filippatos; Mustafa I Ahmed; Ami E Iskandrian; Vera Bittner; Gilbert J Perry; Michel White; Inmaculada B Aban; Marjan Mujib; Louis J Dell'Italia; Ali Ahmed
Journal:  Circulation       Date:  2010-01-04       Impact factor: 29.690

10.  Determination of reference values for tricuspid annular plane systolic excursion in healthy Turkish children.

Authors:  Fahrettin Uysal; Özlem Mehtap Bostan; Ergun Çil
Journal:  Anatol J Cardiol       Date:  2015-05-05       Impact factor: 1.596

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.